Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies
Saved in:
Main Authors: | Benjamin Thiele, Paul Schmidt-Barbo, Christoph Schultheiss, Edith Willscher, Thomas Weber, Mascha Binder |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-025-56395-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies
by: Mathieu Ferrari, et al.
Published: (2025-01-01) -
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies
by: Mathieu Ferrari, et al.
Published: (2024-02-01) -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS
by: Ugo Testa, et al.
Published: (2024-01-01) -
Cerebrospinal fluid‐specific oligoclonal bands in dogs with idiopathic epilepsy
by: Junwei Föhr, et al.
Published: (2025-01-01) -
Dual-targeting CAR T cells for B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma
by: Gustavo de Oliveira Canedo, et al.
Published: (2025-02-01)